Collegium制药公司第四季度每股收益$1.75超出预期$1.54，销售额$1.8195亿亦高于预期$1.7979亿

财报速递02-27
Collegium制药公司(NASDAQ: COLL)报告季度每股收益$1.75，超出分析师共识预期的$1.54，超出幅度为13.64%。这比去年同期的每股收益$1.58增加了10.76%。公司报告季度销售额为$1.8195亿，超出分析师共识预期的$1.7979亿，超出幅度为1.20%。这比去年同期的销售额$1.4975亿增加了21.51%。

以上内容来自Benzinga Earnings专栏，原文如下：

Collegium Pharmaceutical (NASDAQ:COLL) reported quarterly earnings of $1.75 per share which beat the analyst consensus estimate of $1.54 by 13.64 percent. This is a 10.76 percent increase over earnings of $1.58 per share from the same period last year. The company reported quarterly sales of $181.95 million which beat the analyst consensus estimate of $179.79 million by 1.20 percent. This is a 21.51 percent increase over sales of $149.75 million the same period last year.

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白
发表看法